Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid beta ...
The company’s AI emphasizes creative control, letting users adjust aspects of videos and animations, rather than simply ...
Apple today released a new update for Safari Technology Preview, the experimental browser that was first introduced in March ...
A cultural and technological alliance redefining sound, self-expression, and premium audio innovation for Morocco’s new ...
Storm-2945, a sub-cluster of the Russian threat actor Midnight Blizzard, has been observed compromising the sign-in portals ...
Kriya Therapeutics, Inc. (“Kriya”), a biotechnology company committed to building durable medicines that can scale, today announced the publication of preclinical data demonst ...
SUNNYVALE, Calif.--(BUSINESS WIRE)--Aug 5, 2026-- ...
AURORA, Ill.--(BUSINESS WIRE)--Aug 5, 2026-- ...
Spokane, WA / Storyteller / Jul 27, 2026 / ...
TUESDAY, AUG. 4 ...
LONDON, UK / ACCESS Newswire / August 4, 2026 / The Company announces that on 03 August 2026 it purchased the following ...
TURIN, Italy--(BUSINESS WIRE)--Jul 28, 2026-- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results